title: Surgery. β-Blockers--still a trusted ally or time for retirement?
abstract: Uncertainty surrounds the benefit of β-blocker treatment in various clinical settings. The researchers in a new retrospective analysis of preoperative β-blocker use in CABG surgery now add to the debate, and suggest that these drugs might not improve perioperative outcomes.
authors: The Samuel and Jean A. Frankel Cardiovascular Center, Office 2706-SPC 5853, 1500 East Medical Center Drive, Ann Arbor, Michigan 48109, USA.
authors: Prashant
authors: P
authors: Vaishnava
authors: The Samuel and Jean A. Frankel Cardiovascular Center, Office 2706-SPC 5853, 1500 East Medical Center Drive, Ann Arbor, Michigan 48109, USA.
authors: Kim A
authors: KA
authors: Eagle
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000453:epidemiology*; D001026:Coronary Artery Bypass / Q000379:methods*; D005260:Female; D006801:Humans; D008297:Male; D011183:Postoperative Complications / Q000453:epidemiology*; D011300:Preoperative Care / Q000379:methods*; D051437:Renal Insufficiency / Q000453:epidemiology*; D012121:Respiration, Artificial / Q000706:statistics & numerical data*; D020521:Stroke / Q000453:epidemiology*
chemical_list: D000319:Adrenergic beta-Antagonists